Biomedical Production Technologies. From Organ-on-Chip to Artificial Organs

The aim of the NXTGEN HIGHTECH investment program is to use the special high-tech competencies available in the Netherlands to become the leading high-tech cluster in Europe. Recently the Dutch government decided to invest 450 million Euro in this program out of the Dutch Growth Fund, that is aimed at a structural and sustainable growth of the Dutch Economy. One of the six domains of NXTGEN HIGHTECH is ‘Biomedical Production Technologies’ in which the Holst Centre will play an important role. The aim of this domain is to develop production technology and building blocks for the next generation of chips for miniature diagnostics (Lab-on-Chip), to mimic organs (Organ-on-Chip) and to replace organs (Artificial Organs).

In this break-out session, Albert van Breemen and Lucas Lindeboom will introduce the Biomedical Production Technologies domain of NXTGEN HIGHTECH and highlight the current status and outlook of the Organ-on-Chip and Artificial Organ activities within Holst Centre.

Round 1: 13.15 - 13:45